RNS Number : 0184W
Spire Healthcare Group PLC
12 April 2023
 

12 April 2023

 

Spire Healthcare Group plc (the Company)

 

Exercise of Executive Share Plan awards

On 11 April 2023, Justin Ash and Jitesh Sodha, both Executive Directors of the Company, exercised their vested:

·    Long Term Incentive Plan award in the Company that were granted on 28 March 2018 (the 2018 LTIP award). 2018 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2020 Annual Report and Accounts. On vesting in March 2021, the 2018 LTIP awards were subject to a further two-year holding period which ended at the end of March 2023; and

·    Deferred Share Bonus Plan award that were granted on 6 April 2020 (the 2020 DSBP award). 2020 DSBP awards were subject to a three-year holding period which ended on the third anniversary of the award being made.

 

Following the exercise by both Directors of their 2018 LTIP awards and 2020 DSBP awards over ordinary shares in the Company and after the satisfaction of taxes due, both decided to retain the balance of ordinary shares.

 

 

Share plan and type of award

Shares vested and exercised

Shares retained following satisfaction of taxes due

Justin Ash

2018 LTIP (in the form of nil-cost options)

 

108,874

57,703

Justin Ash

 

2020 DSBP (in the form of nil-cost options)

 

170,833

90,541

Total number of shares retained

148,244

 

Following the transactions, Justin Ash holds 578,268 ordinary shares in the Company.

 

 

Share plan and type of award

Shares vested and exercised

Shares retained following satisfaction of taxes due

Jitesh Sodha

2018 LTIP (in the form of nil-cost options)

 

78,287

41,492

Jitesh Sodha

 

2020 DSBP (in the form of nil-cost options)

 

73,140

38,764

Total number of shares retained

80,256

 

Following the transactions, Jitesh Sodha holds 134,058 ordinary shares in the Company.

 

 

Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justinian Joseph Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014.

 

Following the exercise by Mr Ash of his award over 108,874 ordinary shares and after the satisfaction of taxes due, a balance of 57,703 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

108,874

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2023-04-11

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Jitesh Himatlal Sodha

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014.

 

Following the exercise by Mr Sodha of his award over 78,287 ordinary shares and after the satisfaction of taxes due, a balance of 41,492 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

78,287

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2023-04-11

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justinian Joseph Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Deferred Share Bonus Plan 2014.

 

Following the exercise by Mr Ash of his award over 170,833 ordinary shares and after the satisfaction of taxes due, a balance of 90,541 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

170,833

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2023-04-11

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Jitesh Himatlal Sodha

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Deferred Share Bonus Plan 2014.

 

Following the exercise by Mr Sodha of his award over 73,140 ordinary shares and after the satisfaction of taxes due, a balance of 38,764 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

73,140

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2023-04-11

f)

Place of the transaction

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDSGDBDGXD